213 related articles for article (PubMed ID: 10875033)
1. Response to changing plasma concentrations of isosorbide-bound NO2 during acute and sustained treatment with isosorbide dinitrate in patients with coronary artery disease.
Jørgensen LH; Thaulow E; Bredesen J; Refsum HE
Clin Cardiol; 2000 Jun; 23(6):427-32. PubMed ID: 10875033
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic time course of acute and chronic isosorbide dinitrate treatment at rest and during exercise in patients with stable ischemic heart disease.
Jørgensen LH; Thaulow E; Refsum HE
Clin Cardiol; 1996 Sep; 19(9):718-24. PubMed ID: 8874991
[TBL] [Abstract][Full Text] [Related]
3. Effects of isosorbide dinitrate on electrocardiography, hemodynamics, and ventilation in patients with exercise-induced elevation of pulmonary artery wedge pressure.
Jørgensen LH; Thaulow E; Refsum HE
Clin Cardiol; 1999 Oct; 22(10):623-8. PubMed ID: 10526685
[TBL] [Abstract][Full Text] [Related]
4. Randomized study to evaluate the relation between oral isosorbide dinitrate dosing interval and the development of early tolerance to its effect on left ventricular filling pressure in patients with chronic heart failure.
Elkayam U; Roth A; Mehra A; Ostrzega E; Shotan A; Kulick D; Jamison M; Johnston JV; Rahimtoola SH
Circulation; 1991 Nov; 84(5):2040-8. PubMed ID: 1934379
[TBL] [Abstract][Full Text] [Related]
5. Influence of glyceryl trinitrate on venous and arterial effects of chronic, asymmetric isosorbide dinitrate treatment in patients with ischemic heart disease.
Jørgensen LH; Refsum HE; Thaulow E
Clin Cardiol; 1994 Feb; 17(2):65-70. PubMed ID: 8162628
[TBL] [Abstract][Full Text] [Related]
6. Short and long-acting oral nitrates for stable angina pectoris.
Thadani U; Lipicky RJ
Cardiovasc Drugs Ther; 1994 Aug; 8(4):611-23. PubMed ID: 7848896
[TBL] [Abstract][Full Text] [Related]
7. Early hemodynamic effects at rest with acute and chronic isosorbide dinitrate treatment in patients with ischemic heart disease.
Jørgensen LH; Thaulow E; Refsum HE
Clin Cardiol; 1995 Aug; 18(8):455-9. PubMed ID: 7586763
[TBL] [Abstract][Full Text] [Related]
8. Effects of sublingual nitrate in patients receiving sustained therapy of isosorbide dinitrate for coronary artery disease.
Naito H; Matsuda Y; Shiomi K; Yorozu T; Maeda T; Lee H; Seki K; Nakashima H
Am J Cardiol; 1989 Sep; 64(10):565-8. PubMed ID: 2782246
[TBL] [Abstract][Full Text] [Related]
9. Nitrate tolerance: hemodynamic effects of intravenous isosorbide dinitrate after sustained oral isosorbide dinitrate administration.
Kumagae H; Koiwaya Y; Tanaka K
Clin Ther; 1990; 12(1):31-43. PubMed ID: 2328526
[TBL] [Abstract][Full Text] [Related]
10. Antianginal and anti-ischemic efficacy of nicorandil in comparison with isosorbide-5-mononitrate and isosorbide dinitrate: results from two multicenter, double-blind, randomized studies with stable coronary heart disease patients.
Döring G
J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S74-81. PubMed ID: 1282180
[TBL] [Abstract][Full Text] [Related]
11. Differences in the production of methemoglobin during high-dose treatment with isosorbide dinitrate or isosorbide 5-mononitrate.
Schneider W; Stahl B; Kaltenbach M; Bussmann WD
Arzneimittelforschung; 1984; 34(12):1779-82. PubMed ID: 6543314
[TBL] [Abstract][Full Text] [Related]
12. [Development of tolerance with regard to the anti-ischemic effect of isosorbide dinitrate in regular multiple daily administration].
Reiniger G; Blasini R; Brügmann U; Rudolph W
Herz; 1984 Jun; 9(3):146-52. PubMed ID: 6430768
[TBL] [Abstract][Full Text] [Related]
13. Double-blind randomized multicenter study on the efficacy of trapidil versus isosorbide dinitrate in stable angina pectoris.
Raubach KH; Vlahov V; Wolter K; Bussmann WD
Clin Cardiol; 1997 May; 20(5):483-8. PubMed ID: 9134282
[TBL] [Abstract][Full Text] [Related]
14. Discordance of anti-ischemic and hemodynamic effects of captopril in stable coronary artery disease.
Winkelmann BR; Matheis G; Kleist P; Pötter S; Wohltmann D; Kaltenbach M
Coron Artery Dis; 1994 Oct; 5(10):829-44. PubMed ID: 7866603
[TBL] [Abstract][Full Text] [Related]
15. Plasma concentrations and coronary vasodilation after sublingual and intracoronary administration of isosorbide dinitrate.
Hoshio A; Shirota K; Sasaki N; Doi T; Sawada Y; Fukuki M; Miyakoda H; Kotake H; Mashiba H
Clin Cardiol; 1995 Nov; 18(11):641-6. PubMed ID: 8590533
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the time to onset of action on myocardial ischaemia following intravenous administration of isosorbide dinitrate and 5-isosorbide mononitrate in Chinese patients.
Wu ZG; Li JN; Fan M; Shang YK; Zhang YW; Bai J; Ding R; Cheng JM; Liang C
Arzneimittelforschung; 2004; 54(5):275-9. PubMed ID: 15212189
[TBL] [Abstract][Full Text] [Related]
17. Lack of bioequivalence between different formulations of isosorbide dinitrate and hydralazine and the fixed-dose combination of isosorbide dinitrate/hydralazine: the V-HeFT paradox.
Tam SW; Sabolinski ML; Worcel M; Packer M; Cohn JN
Clin Pharmacokinet; 2007; 46(10):885-95. PubMed ID: 17854237
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the antianginal efficacy of isosorbide dinitrate (ISDN) 40 mg and verapamil 120 mg three times daily in the acute trial and following two-week treatment.
Schneider W; Maul FD; Bussmann WD; Lang E; Hör G; Kaltenbach M
Eur Heart J; 1988 Feb; 9(2):149-58. PubMed ID: 3280317
[TBL] [Abstract][Full Text] [Related]
19. [Plasma levels of isosorbide dinitrate and its metabolites during intravenous infusion in surgical patients--effect of preoperative administration of isosorbide dinitrate].
Murakawa T; Hashimoto Y; Sato T; Takagi H; Kushikata T; Araki I; Kou H; Kimura F; Matsuki A
Masui; 1993 Feb; 42(2):225-32. PubMed ID: 8437354
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of nitrate tolerance in patients with coronary heart disease by vascular ultrasonography and treadmill exercise.
Yu GL; Zhuang HP; Wang ZH; Liao JT
Int J Cardiol; 1999 May; 69(2):133-7. PubMed ID: 10549836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
